A new boron agent drastically improves the effectiveness of boron neutron capture therapy for glioblastoma, demonstrate researchers at Tokyo Tech. The agent is selectively absorbed by brain tumor ...
Malignant gliomas, including glioblastoma, are among the most aggressive and deadly brain tumors. Even with surgery, radiation, and chemotherapy, most patients survive little more than a year after ...
IRVINE, Calif.--(BUSINESS WIRE)--TAE Life Sciences, in collaboration with Kyoto University and Principal Investigator Dr. Fuyuhiko Tamanoi, is pleased to announce groundbreaking preclinical results in ...
NEW YORK--(BUSINESS WIRE)--Aviko Radiopharmaceuticals, a Deerfield Management-founded biotechnology company, is advancing precision boron neutron capture therapy (BNCT) to treat a variety of cancers ...
Researchers from the Health Research and Technology Group at ANSTO and the University of Wollongong have developed a new device that could improve the quality control of accelerator-based boron ...
Distribution and failure patterns of primary central nervous system lymphoma related to the hippocampus: Implications for hippocampal sparing irradiation. This is an ASCO Meeting Abstract from the ...
Boron neutron capture therapy is being used in Japan to target and treat head and neck tumours. Many other countries are now building facilities. In 2020, Japan became the first country to approve ...
Boron agents termed GluBs, developed by Science Tokyo researchers, have overcome a key limitation in cancer therapy by entering tumor cells through a pathway that standard drugs cannot use. The GluBs ...
In its first trial designed to evaluate boron neutron capture therapy (BNCT) in the treatment of advanced refractory malignant tumors, Neuboron Medtech Ltd. has performed 14 irradiations on a dozen ...
Cosylab and Heron Neutron Medical Corp. announced today, 10 June 2026, the signing of a Letter of Intent to establish a strategic framework for joint market development to support the global ...
A new technique has measured boron in individual cancer cells for the first time, enabling researchers to better understand how drugs act to kill tumours in some cancers. In a new article in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results